Study confirms Novavax immunogenicity but with slightly weaker immune response compared to mRNA vaccines
The Novavax COVID-19 vaccine was approved in Germany this February, followed by the U.S. in mid-July. Immunology professor Martina Sester and her team have now studied how Novavax recipients respond to the vaccine. The study ...
Aug 11, 2022
0
4